Victor Bloniecki

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels

Victor Bloniecki, Dag Aarsland, Jeffrey L. Cummings et al. · Dementia and Geriatric Cognitive Disorders Extra · 2014 · 38 citations · Full text

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?

Victor Bloniecki, Henrik Zetterberg, Dag Aarsland et al. · Alzheimer s Research & Therapy · 2020 · 19 citations · Full text

Digital Screening for Cognitive Impairment — A Proof of Concept Study

Victor Bloniecki, Göran Hagman, Marie Rydén et al. · The Journal of Prevention of Alzheimer s Disease · 2021 · 16 citations · Full text

Galantamine versus Risperidone for Agitation in People with Dementia: A Randomized, Twelve-Week, Single-Center Study

Yvonne Freund‐Levi, Victor Bloniecki, Bjørn Auestad et al. · Dementia and Geriatric Cognitive Disorders · 2014 · 14 citations

Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid

Victor Bloniecki, Dag Aarsland, Kaj Blennow et al. · Journal of Alzheimer s Disease · 2017 · 14 citations · Full text